BCL7B antibody
-
- Target See all BCL7B Antibodies
- BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))
- Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BCL7B antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Purification
- Immunogen affinity purified
- Purity
- ≥95 % as determined by SDS-PAGE
- Immunogen
- B-cell CLL/lymphoma 7B
- Isotype
- IgG
- Top Product
- Discover our top product BCL7B Primary Antibody
-
-
- Application Notes
- WB: 1:500-1:2000, IHC: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Expiry Date
- 12 months
-
- Target
- BCL7B (B-Cell CLL/lymphoma 7B (BCL7B))
- Alternative Name
- BCL7B (BCL7B Products)
- Background
- Synonyms: Background:Positive regulator of apoptosis. Plays a role in the Wnt signaling pathway, negatively regulating the expression of Wnt signaling components CTNNB1 and HMGA1(PubMed:25569233). Involved in cell cycle progression, maintenance of the nuclear structure and stem cell differentiation(PubMed:25569233). May play a role in lung tumor development or progression(By similarity).
- Molecular Weight
- 45 kDa
- Gene ID
- 9275
- UniProt
- Q9BQE9
-